Challenges To The Indian Drug Industry Subtle, Manifold and More Potent Now, Pharma Lobby Tells Government
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A spate of adverse moves by developed countries and international agencies in the past year have been most challenging for the Indian drug industry, says the Indian Pharmaceutical Alliance - the lobby of top Indian generic drug makers
You may also be interested in...
Indian Commerce Minister Speaks Strongly Against EU Drug Seizures
Recent seizures of Indian generic drugs bound for other destinations transiting through European ports are one of many attempts to discredit Indian generic drugs, visiting Indian Commerce & Industry Minister Anand Sharma told reporters in Washington on June 18 during a press briefing
India’s Pitch To Oppose “Automatic Patenting” Gets Louder With Moves To Seek China’s Support
MUMBAI - India is mobilizing support from China in countering a move by the World Intellectual Property Organization and the U.S. for a global patenting system that, according to India, is "pushing for the automatic grant of patents in all member states." Senior officials from Indian pharmaceutical companies and associations are currently on a visit to Beijing to persuade Chinese officials on the implications of the proposed new system
India Opposes Seizure Of Drugs By EU Even As Dr. Reddy’s Labs Brings Its Goods Back
MUMBAI - Stung by strictures on Indian companies routing drug consignments through the European Union, the Indian government is considering drastic measures in a bid to control further damage to India's pharmaceutical trade